Minimal Residual Disease in Acute Lymphoblastic Leukaemia—PCR Analysis of Immunoglobulin Gene Rearrangements

References

• Hoelzer D., Gale R. P. Acute lymphoblastic leukaemia in adults: recent progress, future directions. Semin. Haematol. 1987; 24: 27–39
   PubMed Web of Science ®Google Scholar
• Eden O. B., Lilleyman J. S., Richards S., Shaw M. P., Peto J. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (Report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood). Br. J. Haematol. 1991; 78: 187–196
   PubMed Web of Science ®Google Scholar
• Hagenbeek A. Minimal residual disease in leukaemia: state of the art 1991. Leukemia 1992; 6(Suppl. 2)12–16
   PubMedGoogle Scholar
• Korsmeyer S. J. Antigen receptor genes as molecular markers of lymphoid neoplasms. J. Clin. Invest. 1987; 79: 1921–1925
   Google Scholar
• Felix C. A., Poplack D. G., Reaman G. H., Steinberg S. M., Cole D. E., Taylor B. J., Begley C. G., Kirsch I. R. Characterisation of immunoglobulin and T-cell receptor gene patterns in B-cell precursor acute lymphoblastic leukaemia of childhood. J. Clin. Oncol. 1990; 8: 431–442
   PubMed Web of Science ®Google Scholar
• Tonegawa S. Somatic generation of antibody diversity. Nature 1983; 302: 575–581
   PubMed Web of Science ®Google Scholar
• Deane M., Norton J. D. Detection of immunoglobulin gene rearrangement in B lymphoid malignancies by polymerase chain reaction gene amplification. Br. J. Haematol. 1990; 74: 251–256
   PubMed Web of Science ®Google Scholar
• Deane M., Norton J. Immunoglobulin gene “fingerprinting”: an approach to analysis of B lymphoid clonality in lymphoproliferative disorders. Br. J. Haematol. 1991; 77: 274–281
   PubMed Web of Science ®Google Scholar
• Foroni L., Mason P. J., Luzzatto L. Immunoglobulin and T-cell receptor gene analysis for the investigation of lymphoproliferative disorders. The Leukaemic Cell—Methods in Haematology, 2nd edn, D. Catovsky. Churchill Livingstone, New York 1990; 339–391
   Google Scholar
• Chirgwin J. M., Przyblyla A. E., MacDonald R. I., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–5299
   PubMed Web of Science ®Google Scholar
• Sarkar G., Sommer S. S. Shedding light on PCR contamination. Nature 1990; 343: 27
   PubMed Web of Science ®Google Scholar
• Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbour Laboratory Press, New York 1989
   Google Scholar
• Kwok S., Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237–238
   PubMed Web of Science ®Google Scholar
• Nakajima-Iijima S., Hamada H., Reddy P., Kakunaga T. Molecular structure of the human cytoplasmic β-actin gene: Intraspecies homology of sequences in the introns. Proc. Natl. Acad. Sci. USA 1985; 82: 6133–6137
   PubMed Web of Science ®Google Scholar
• Porfiri E., Secker-Walker L. M., Hoffbrand A. V., Hancock J. F. H. DCC tumour suppressor gene is inactivated in hematologic malignancies showing monosomy 18. Blood 1993; 81: 2696–2701
   PubMed Web of Science ®Google Scholar
• Potter M. N., Steward C. G., Maitland N. J., Oakhill A. Detection of clonality in childhood B-lineage acute lymphoblastic leukaemia by the polymerase chain reaction. Leukemia 1992; 6: 289–294
   PubMed Web of Science ®Google Scholar
• Trainor K. J., Brisco M. J., Story C. J., Morley A. A. Monoclonality in B-lymphoproliferative disorders detected at the DNA level. Blood 1990; 75: 2220–2222
   PubMed Web of Science ®Google Scholar
• McCarthy K. P., Sloane J. P., Wiedemann L. M. Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens. J. Clin. Pathol. 1990; 43: 429–432
   PubMed Web of Science ®Google Scholar
• Deane M., McCarthy K. P., Wiedemann L. M., Norton J. D. An improved method for detection of B-lymphoid clonality by polymerase chain reaction. Leukemia 1991; 5: 726–730
   PubMed Web of Science ®Google Scholar
• Deane M., Pappas H., Norton J. D. Immunoglobulin heavy chain gene fingerprinting reveals widespread oligoclonality in B-lineage acute lymphoblastic leukaemia. Leukemia 1991; 5: 832–838
   PubMed Web of Science ®Google Scholar
• Katz F., Ball L., Chessels J. The use of DNA probes to monitor minimal residual disease in childhood acute leukaemia. Br. J. Haematol. 1989; 73: 173–180
   PubMed Web of Science ®Google Scholar
• Kitchingman G. R. Immunoglobulin heavy chain gene VH-D junctional diversity at diagnosis in patients with acute lymphoblastic leukaemia. Blood 1993; 81: 775–782
   PubMed Web of Science ®Google Scholar
• Bird J., Galili N., Link M., Stites D., Sklar J. Continuing rearrangements but absence of somatic hypermutations in immunoglobulin genes of human B cell precursor leukaemia. J. Exp. Med. 1988; 168: 229–245
   PubMed Web of Science ®Google Scholar
• Rovera G., Wasserman R., Yamada M. Detection of minimal residual disease in childhood leukaemia by the polymerase chain reaction. N. Engl. J. Med. 1991; 324: 774, letter
   Web of Science ®Google Scholar
• Wasserman R., Yamada M., Ito Y. VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia. Blood 1992; 79: 223–228
   PubMed Web of Science ®Google Scholar
• Deane M., Norton J. D. Immunoglobulin heavy chain variable region family usage is independent of tumour cell phenotype in human B lineage leukemias. Eur. J. Immunol. 1990; 20: 2209–2217
   PubMed Web of Science ®Google Scholar
• Kodaira M., Kinashi T., Umemura I., Matsuda F., Noma T., Ono Y., Honjo T. Organisation and evolution of variable region genes of the human immunoglobulin heavy chain. J. Mol. Biol. 1986; 190: 529–541
   PubMed Web of Science ®Google Scholar
• Berman J. E., Mellis S. J., Pollock R., Smith C. L., Suh H., Heinke B., Kowal C., Surti U., Chess L., Cantor C. R., Alt F. W. Content and organisation of the human Ig VH locus: definition of three new VH family and linkage to the Ig CH locus. Eur. Mol. Biol. Org. J. 1988; 7: 727–738
   PubMed Web of Science ®Google Scholar
• Bartram C. R., Yokota S., Biondi A., Janssen J. W. G., Hansen-Hagge T. E. Detection of minimal residual disease in acute lymphoblastic leukaemia by polymerase chain reactions. Haematol. Blood Transfusion 1992; 34: 171–177
   Google Scholar
• Yamada M., Wasserman R., Lange B., Reichard B. A., Womer R. B., Rovera G. Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells in the first 18 months of treatment. N. Engl. J. Med. 1990; 323: 488–495
   Web of Science ®Google Scholar
• Nizet Y., Martiat P., Vaerman J. L., Philippe M., Wild-Mann C., Staelens J. P., Cornu C., Ferrant A., Michaux J. L., Sokal G. Follow up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome. Br. J. Haematol. 1991; 79: 205–210
   PubMed Web of Science ®Google Scholar
• Borella L., Green A. A., Webster R. G. Im-munological rebound after cessation of long-term chemotherapy in acute leukaemia. Blood 1973; 40: 42–51
   Google Scholar
• Biondi A., Yokota S., Hansen-Hagge T. E., Rossi V., Giudici G., Maglia O., Basso G., Tell C., Masera G., Bartram C. R. Minimal residual disease in childhood acute lymphoblastic leukaemia: analysis of patients in continuous complete remission or with consecutive relapse. Leukemia 1992; 6: 282–288
   PubMed Web of Science ®Google Scholar
• Potter M. N., Steward C. G., Oakhill A. The significance of minimal residual disease in childhood acute lymphoblastic leukaemia. Br. J. Haematol. 1993; 83: 412–418
   PubMed Web of Science ®Google Scholar
• Kabat E. A., Wu T. T., Reid-Miller M., Perry H. M., Gottesman K. S. Sequences of proteins of immuno-logical interest, 4th edn. US Department of Health and Human Services NIH. 1987
   Google Scholar